Susquehanna International Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.9M Sell
14,061
-6,003
-30% -$3.85M ﹤0.01% 3482
2025
Q4
$13.6M Sell
20,064
-2,457
-11% -$1.67M ﹤0.01% 2668
2025
Q3
$14.4M Buy
22,521
+2,934
+15% +$1.78M ﹤0.01% 2558
2025
Q2
$10.5M Buy
19,587
+10,786
+123% +$5.16M ﹤0.01% 2760
2025
Q1
$3.7M Sell
8,801
-35,450
-80% -$15.4M ﹤0.01% 4239
2024
Q4
$18.3M Buy
44,251
+32,739
+284% +$14.4M ﹤0.01% 1945
2024
Q3
$5.82M Sell
11,512
-32,194
-74% -$15.6M ﹤0.01% 3351
2024
Q2
$21.3M Buy
43,706
+7,864
+22% +$3.95M ﹤0.01% 1657
2024
Q1
$19.4M Sell
35,842
-18,992
-35% -$10.4M ﹤0.01% 1813
2023
Q4
$30.4M Buy
54,834
+19,646
+56% +$9.22M 0.01% 1400
2023
Q3
$15.4M Buy
35,188
+8,092
+30% +$4.04M ﹤0.01% 2046
2023
Q2
$13.6M Sell
27,096
-23,096
-46% -$11.1M ﹤0.01% 2127
2023
Q1
$25.1M Buy
50,192
+1,590
+3% +$761K 0.01% 1475
2022
Q4
$19.8M Buy
48,602
+32,568
+203% +$12.6M 0.01% 1531
2022
Q3
$5.22M Sell
16,034
-26,375
-62% -$9.69M ﹤0.01% 3090
2022
Q2
$14.9M Buy
42,409
+1,973
+5% +$805K ﹤0.01% 1728
2022
Q1
$22.1M Buy
40,436
+18,843
+87% +$9.91M ﹤0.01% 1629
2021
Q4
$14.2M Buy
21,593
+852
+4% +$535K ﹤0.01% 2242
2021
Q3
$12.9M Sell
20,741
-36,077
-63% -$24.2M ﹤0.01% 2524
2021
Q2
$35.9M Buy
56,818
+19,025
+50% +$10.5M 0.01% 1451
2021
Q1
$18.5M Sell
37,793
-12,906
-25% -$6.47M ﹤0.01% 1972
2020
Q4
$25.3M Buy
50,699
+48,888
+2,700% +$21.9M ﹤0.01% 1493
2020
Q3
$712K Sell
1,811
-15,379
-89% -$5.69M ﹤0.01% 6926
2020
Q2
$5.67M Buy
17,190
+4,630
+37% +$1.34M ﹤0.01% 2829
2020
Q1
$3.04M Sell
12,560
-12,209
-49% -$3.19M ﹤0.01% 3262
2019
Q4
$6.47M Buy
+24,769
New +$6.53M ﹤0.01% 2621
2018
Q4
Sell
-10,107
Closed -$2.07M 9379
2018
Q3
$2.52M Buy
10,107
+7,769
+332% +$1.89M ﹤0.01% 3628
2018
Q2
$510K Buy
2,338
+1,292
+124% +$266K ﹤0.01% 6741
2018
Q1
$200K Sell
1,046
-17,421
-94% -$3.22M ﹤0.01% 8327
2017
Q4
$2.89M Buy
+18,467
New +$2.91M ﹤0.01% 3307
2017
Q3
Sell
-32,288
Closed -$5.1M 9174
2017
Q2
$5.21M Buy
32,288
+1,926
+6% +$313K ﹤0.01% 2362
2017
Q1
$4.69M Sell
30,362
-36,044
-54% -$4.97M ﹤0.01% 2434
2016
Q4
$7.79M Buy
66,406
+8,637
+15% +$986K ﹤0.01% 1820
2016
Q3
$6.51M Buy
57,769
+38,175
+195% +$4.02M ﹤0.01% 1936
2016
Q2
$1.82M Buy
19,594
+2,028
+12% +$174K ﹤0.01% 3742
2016
Q1
$1.38M Buy
17,566
+3,566
+25% +$257K ﹤0.01% 4473
2015
Q4
$1.02M Sell
14,000
-31,007
-69% -$2.21M ﹤0.01% 5358
2015
Q3
$3.34M Sell
45,007
-55,258
-55% -$3.96M ﹤0.01% 3308
2015
Q2
$6.43M Buy
100,265
+23,279
+30% +$1.61M ﹤0.01% 2547
2015
Q1
$5.95M Buy
76,986
+2,542
+3% +$198K ﹤0.01% 2498
2014
Q4
$5.52M Sell
74,444
-159,870
-68% -$11.2M ﹤0.01% 2749
2014
Q3
$13.8M Buy
234,314
+27,362
+13% +$1.73M 0.01% 1765
2014
Q2
$13.8M Sell
206,952
-6,522
-3% -$415K 0.01% 1764
2014
Q1
$13M Buy
213,474
+22,288
+12% +$1.33M 0.01% 1707
2013
Q4
$10.2M Buy
191,186
+168,138
+730% +$8.85M ﹤0.01% 2049
2013
Q3
$1.15M Sell
23,048
-32,614
-59% -$1.57M ﹤0.01% 5047
2013
Q2
$2.5M Buy
+55,662
New +$2.43M ﹤0.01% 3563

Other funds holding IDXX

Susquehanna International Group's IDXX Position: Q1 2026 in Review

Susquehanna International Group reduced its Idexx Laboratories (IDXX) stake by 30% in Q1 2026, selling an estimated $3.85M and leaving 14,061 shares worth $7.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3482.

Susquehanna International Group first reported a position in IDXX in Q2 2013 and has held it in 47 quarters since. The position peaked at $35.9M in Q2 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Susquehanna International Group held 14,061 shares of Idexx Laboratories worth $7.9M as of Q1 2026.
  • Susquehanna International Group sold 6,003 Idexx Laboratories shares in Q1 2026, an estimated $3.85M.
  • Idexx Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3482 holding.
  • Susquehanna International Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Idexx Laboratories position peaked at $35.9M in Q2 2021.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.